NCT00003727View on ClinicalTrials.gov

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

March 31, 2005

Study Completion Date

February 29, 2008

Conditions
Leukemia
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

recombinant interferon alfa

BIOLOGICAL

sargramostim

BIOLOGICAL

therapeutic autologous lymphocytes

DRUG

carmustine

DRUG

cyclophosphamide

DRUG

etoposide

DRUG

gemcitabine hydrochloride

DRUG

melphalan

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

in vitro-treated peripheral blood stem cell transplantation

Trial Locations (1)

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

All Listed Sponsors
collaborator

University of Maryland Greenebaum Cancer Center

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT00003727 - Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter